Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Immutep LTD ADR

Start price
Target price
Perf. (%)
€2.70
04.05.21
-
04.05.22
-8.89%
05.05.22

Could be very worthwhile Investment >20% year
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€9.99
16.10.21
-
16.10.22
-26.78%
04.05.22

Could be worthwhile Investment >10% per year
buy
HyreCar

Start price
Target price
Perf. (%)
€11.20
02.05.21
€13.00
02.05.22
-86.76%
03.05.22

Could be worthwhile Investment >10% per year
Sino-Global Shipping America Ltd.

Start price
Target price
Perf. (%)
€6.10
16.04.22
€3.00
16.04.23
-11.48%
30.04.22

negative Cash Flow expected
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Alliance MMA Inc

Start price
Target price
Perf. (%)
€0.87
16.04.22
€0.000
16.04.23
-0.64%
30.04.22

Lower EBIT Margin than peer group
Revenue decline/stagnation expected
Little Investments for future growth
Risky balance sheet
DOWA Holdings Inc.

Start price
Target price
Perf. (%)
€42.00
28.03.22
-
28.03.23
-6.67%
29.04.22

Could be worthwhile Investment >10% per year
DOWA Holdings Inc.

Start price
Target price
Perf. (%)
€42.00
28.03.22
-
28.03.23
-6.67%
29.04.22

Could be worthwhile Investment >10% per year
DOWA Holdings Inc.

Start price
Target price
Perf. (%)
€42.00
28.03.22
-
28.03.23
-6.67%
29.04.22

Could be worthwhile Investment >10% per year
DOWA Holdings Inc.

Start price
Target price
Perf. (%)
€42.00
28.03.22
-
28.03.23
-6.67%
29.04.22

Could be worthwhile Investment >10% per year
DOWA Holdings Inc.

Start price
Target price
Perf. (%)
€42.00
28.03.22
-
28.03.23
-6.67%
29.04.22

Could be worthwhile Investment >10% per year
Recon Technology Ltd.

Start price
Target price
Perf. (%)
€7.15
27.04.21
-
27.04.22
-88.99%
28.04.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Montagne et Neige Développement S.A.

Start price
Target price
Perf. (%)
€8.00
21.04.21
€12.00
21.04.22
-58.19%
22.04.22

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.78
19.04.21
-
19.04.22
-58.32%
20.04.22

Could be very worthwhile Investment >20% year
buy
Electro-Sensors Inc

Start price
Target price
Perf. (%)
€3.42
18.04.21
€4.00
18.04.22
25.73%
19.04.22

Could be worthwhile Investment >10% per year
buy
Astrotech Corp.

Start price
Target price
Perf. (%)
€1.01
18.04.21
€2.00
18.04.22
-44.46%
19.04.22

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€16.30
06.04.22
€4.00
06.04.23
-13.48%
18.04.22

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.54
07.04.22
-
07.04.23
-9.24%
18.04.22

Risky Investment
buy
Check Cap Ltd

Start price
Target price
Perf. (%)
€1.21
17.04.21
-
17.04.22
-72.17%
18.04.22

Could be very worthwhile Investment >20% year
buy
Electro-Sensors Inc

Start price
Target price
Perf. (%)
€3.42
17.04.21
-
17.04.22
25.73%
18.04.22

Could be very worthwhile Investment >20% year
buy
Energy Focus Inc.

Start price
Target price
Perf. (%)
€24.22
17.04.21
-
17.04.22
-67.05%
18.04.22

Could be very worthwhile Investment >20% year
buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€134.40
02.04.22
€170.00
02.04.23
-12.50%
16.04.22

Revenue growth > 30% per year expected
Fair valuation
Very capable Management
Very small cyclical dependencies
buy
Baidu Inc. A ADR

Start price
Target price
Perf. (%)
€134.40
02.04.22
€170.00
02.04.23
-12.50%
16.04.22

Revenue growth > 30% per year expected
Fair valuation
Very capable Management
Very small cyclical dependencies
Phio Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€25.19
09.04.22
€12.00
09.04.23
-46.16%
16.04.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Cibox Inter@ctive SA

Start price
Target price
Perf. (%)
€0.15
27.08.21
€0.20
27.08.22
-23.18%
15.04.22

Could be worthwhile Investment >10% per year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.83
13.04.21
-
13.04.22
-60.43%
14.04.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group